ATE534372T1 - Verfahren und zusammensetzungen zur behandlung und prävention von infektionen - Google Patents
Verfahren und zusammensetzungen zur behandlung und prävention von infektionenInfo
- Publication number
- ATE534372T1 ATE534372T1 AT07810662T AT07810662T ATE534372T1 AT E534372 T1 ATE534372 T1 AT E534372T1 AT 07810662 T AT07810662 T AT 07810662T AT 07810662 T AT07810662 T AT 07810662T AT E534372 T1 ATE534372 T1 AT E534372T1
- Authority
- AT
- Austria
- Prior art keywords
- treating
- methods
- compositions
- preventing infections
- antimicrobial agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Eyeglasses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/490,917 US20080020064A1 (en) | 2006-07-21 | 2006-07-21 | Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
PCT/US2007/016485 WO2008011164A2 (en) | 2006-07-21 | 2007-07-20 | Methods and compositions for the treatment and prevention of infections |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE534372T1 true ATE534372T1 (de) | 2011-12-15 |
Family
ID=38957409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07810662T ATE534372T1 (de) | 2006-07-21 | 2007-07-20 | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen |
Country Status (11)
Country | Link |
---|---|
US (2) | US20080020064A1 (de) |
EP (1) | EP2046287B1 (de) |
JP (1) | JP2010500968A (de) |
KR (1) | KR20090031609A (de) |
CN (1) | CN101516330A (de) |
AT (1) | ATE534372T1 (de) |
AU (1) | AU2007275644A1 (de) |
BR (1) | BRPI0714808A2 (de) |
CA (1) | CA2658571A1 (de) |
NZ (1) | NZ574173A (de) |
WO (1) | WO2008011164A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101641104B (zh) * | 2007-03-27 | 2013-06-05 | 大幸药品株式会社 | 感染性皮肤和粘膜疾病治疗药 |
US20100062042A1 (en) * | 2008-07-15 | 2010-03-11 | Basf Catalysts Llc | Methods, Systems and Devices for Administration of Chlorine Dioxide |
EP2389069A1 (de) * | 2009-01-20 | 2011-11-30 | Advanced Vision Research, Inc. | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen |
US8311625B2 (en) | 2009-02-04 | 2012-11-13 | Basf Corporation | Chlorine dioxide treatment for biological tissue |
ES2752008T3 (es) * | 2009-10-30 | 2020-04-02 | Intratus Inc | Métodos y composiciones para la liberación sostenida de fármacos |
US20120190653A1 (en) * | 2011-01-20 | 2012-07-26 | Dow Pharmaceutical Sciences, Inc. | Therapeutic eye drop comprising doxycycline and a stabilizer |
WO2013191168A1 (ja) * | 2012-06-19 | 2013-12-27 | 参天製薬株式会社 | 完全フロイントアジュバント投与による眼瞼状態の変化方法 |
US20170049779A1 (en) * | 2013-02-27 | 2017-02-23 | Okinawa Institute Of Science And Technology School Corporation | Flagellar and needle complex (injectosome) loop as anti bacterial drug target |
WO2017210454A1 (en) * | 2016-06-03 | 2017-12-07 | The Regents Of The University Of Colorado, A Body Corporate | Ophthalmic disinfecting agent and methods of using the same |
WO2018204905A1 (en) | 2017-05-05 | 2018-11-08 | Pamel Gregory J | Composition containing chlorine dioxide and methods for using same |
CA3097998A1 (en) | 2018-04-27 | 2019-10-31 | Allergan, Inc. | Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity |
US10292998B1 (en) | 2018-08-07 | 2019-05-21 | Ahad Mahootchi | Compositions and methods for prevention and treatment of eye infections |
PT3672405T (pt) | 2018-11-13 | 2020-11-04 | Csp Technologies Inc | Agentes de libertação de gás antimicrobiano e sistemas e métodos para uso dos mesmos |
AU2019445709A1 (en) * | 2019-05-16 | 2021-11-18 | Csp Technologies, Inc. | Antimicrobial gas releasing agents and systems and methods for using the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499077A (en) * | 1981-02-03 | 1985-02-12 | Stockel Richard F | Anti-microbial compositions and associated methods for preparing the same and for the disinfecting of various objects |
FR2558062B1 (fr) * | 1984-01-17 | 1988-04-22 | Morgan George | Preparation medicamenteuse administrable par voie orale pour le traitement du rhume et/ou de la grippe |
US5736165A (en) * | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
US6024954A (en) * | 1994-12-12 | 2000-02-15 | Allergan | Compositions and methods for disinfecting contact lenses and preserving contact lens care products |
AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
JP2003128584A (ja) * | 2001-08-15 | 2003-05-08 | Rohto Pharmaceut Co Ltd | 水性組成物 |
JP2003128549A (ja) * | 2001-08-15 | 2003-05-08 | Rohto Pharmaceut Co Ltd | 粘膜適用組成物 |
JP2003137781A (ja) * | 2001-08-20 | 2003-05-14 | Rohto Pharmaceut Co Ltd | 眼科用組成物 |
US20050196370A1 (en) * | 2003-03-18 | 2005-09-08 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
US20050028953A1 (en) * | 2003-08-05 | 2005-02-10 | Severeid David E. | Methods for making carboxylated pulp fibers |
-
2006
- 2006-07-21 US US11/490,917 patent/US20080020064A1/en not_active Abandoned
-
2007
- 2007-07-20 KR KR1020097002483A patent/KR20090031609A/ko not_active Application Discontinuation
- 2007-07-20 WO PCT/US2007/016485 patent/WO2008011164A2/en active Application Filing
- 2007-07-20 EP EP07810662A patent/EP2046287B1/de not_active Not-in-force
- 2007-07-20 CA CA002658571A patent/CA2658571A1/en not_active Abandoned
- 2007-07-20 NZ NZ574173A patent/NZ574173A/en not_active IP Right Cessation
- 2007-07-20 AT AT07810662T patent/ATE534372T1/de active
- 2007-07-20 BR BRPI0714808-9A patent/BRPI0714808A2/pt not_active IP Right Cessation
- 2007-07-20 AU AU2007275644A patent/AU2007275644A1/en not_active Abandoned
- 2007-07-20 CN CNA2007800342401A patent/CN101516330A/zh active Pending
- 2007-07-20 JP JP2009520859A patent/JP2010500968A/ja not_active Abandoned
-
2013
- 2013-02-25 US US13/775,889 patent/US20130171239A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2658571A1 (en) | 2008-01-24 |
US20080020064A1 (en) | 2008-01-24 |
JP2010500968A (ja) | 2010-01-14 |
CN101516330A (zh) | 2009-08-26 |
US20130171239A1 (en) | 2013-07-04 |
EP2046287A2 (de) | 2009-04-15 |
EP2046287A4 (de) | 2010-07-28 |
KR20090031609A (ko) | 2009-03-26 |
NZ574173A (en) | 2012-04-27 |
AU2007275644A1 (en) | 2008-01-24 |
EP2046287B1 (de) | 2011-11-23 |
WO2008011164A3 (en) | 2008-10-09 |
WO2008011164A2 (en) | 2008-01-24 |
BRPI0714808A2 (pt) | 2013-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE534372T1 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen | |
WO2007130655A3 (en) | Phage derived antimicrobial activities | |
WO2007085852A3 (en) | Antimicrobial materials | |
MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
TW200734344A (en) | Antibacterial agents | |
WO2007067559A3 (en) | Antibacterial agents | |
MX2012009054A (es) | Tioles de bismuto como antisepticos para usos biomedicos, que incluyen tratamiento de biopeliculas bacterianas y otros usos. | |
MX2019010863A (es) | Tioles de bismuto como antisepticos para usos biomedicos, que incluyen tratamiento de biopeliculas bacterianas y otros usos. | |
ATE439139T1 (de) | Bakteriophage zur behandlung von bakteriellen biofilmen | |
ATE516022T1 (de) | Antimikrobielle zusammensetzungen und anwendungsverfahren dafür | |
WO2018208987A3 (en) | Antibacterial compounds | |
DK1901723T3 (da) | Antimikrobielle materialer | |
MXPA05009352A (es) | Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas. | |
WO2015002932A8 (en) | Antimicrobial compositions comprising hypochlorous acid and silver | |
MX2021003084A (es) | Compuestos antibacterianos. | |
WO2006120563A3 (en) | Antibacterial agents | |
WO2015110969A3 (en) | Nitrogen containing compounds and their use as antibacterial agents | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
AU2010306647A8 (en) | Antimicrobial compounds and methods of making and using the same | |
MX2019006768A (es) | Peptidos antimicrobianos. | |
MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
WO2005054234A3 (en) | Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy | |
ATE495186T1 (de) | Antibakterielle amid-makrozyklen iv | |
ATE528004T1 (de) | Chinolon-antibiotika zur behandlung von periodontaler infektionen |